Target intelligence / Profile preview

RAS family (RAS)

Target
RAS
Molecular classification
Small GTPase, GTP-binding protein, Oncoprotein, Monomeric G protein
01

Overview

The RAS family consists of small GTPases encoded by three main human genes (HRAS, NRAS, KRAS producing four isoforms: HRAS, NRAS, KRAS4A, KRAS4B) that function as molecular switches cycling between GDP-bound inactive and GTP-bound active states to regulate key signaling pathways. They share a conserved G-domain for GTP binding/hydrolysis and effector interactions (e.g., RAF kinases via switch I/II regions), with a hypervariable C-terminal region for membrane anchoring. RAS activates downstream cascades like RAF-MEK-ERK for cell proliferation and survival, and mutations locking GTP-bound state drive ~30% of cancers. Structures reveal β-sheet/α-helix folds akin to EF-Tu, with post-translational modifications (prenylation, acetylation) critical for function

Other names
HRASNRASKRAS (including KRAS4A, KRAS4B)H-RasN-RasK-Rasp21rasRat sarcoma virus proteins
02

Mechanism of action

Direct binding to switch pockets of mutant KRAS to lock inactive conformation, Inhibition of GTP binding, GAP-mediated GTP hydrolysis enhancement, RAF kinase dimerization blockade, Farnesylation blockade for membrane localization

03

Biological functions

Signal transductionCell proliferationCell growthCell differentiationCytoskeletal dynamicsMembrane traffickingActin cytoskeleton regulation
04

Disease associations

CancerTumorigenesis
05

Safety considerations

Oncogenic activation by mutations (e.g., G12/G13/Q61 impairing GTP hydrolysis)Drug resistance in mutantsOff-target effects on wild-type RAS isoformsToxicity from broad pathway inhibition
06

Interacting drugs

Sotorasib (targets KRAS G12C)

3 more in the full profile.

07

Biomarkers

KRAS mutations (e.g., G12C, G12D, G12V)NRAS mutationsHRAS mutationsGTP-bound RAS levels

Beyond the preview

Go deeper on RAS family (RAS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAS family (RAS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call